A Comprehensive Review Of Quality Control And Quality Assurance In The Pharmaceutical Industry

Absrtact: Quality is a central requirement in pharmaceutical products because medicines must consistently meet predefined standards of identity, strength, purity, safety and performance. Quality Control (QC) provides sampling, testing and analytical evidence about materials and products, while Quality Assurance (QA) builds a documented system that prevents errors and ensures that work is performed according to approved procedures. This review synthesises key principles across the major areas of a pharmaceutical QC–QA curriculum: good practices and pharmaceutical quality systems; testing of raw materials, packaging components, in-process samples and finished dosage forms; regulatory authorities and drug-development submissions; documentation and data integrity; qualification, calibration and validation; cleaning and analytical-method validation; Quality by Design (QbD), Process Analytical Technology (PAT), audits and intellectual-property basics. International guidance from WHO, ICH and the US FDA is considered alongside the Indian regulatory context. The literature and guidance indicate that reliable quality depends on a lifecycle approach rather than end-product testing alone. Risk-based decisions, trained personnel, suitable facilities, validated processes, trustworthy data, change control and continual improvement work together to reduce patient risk. Implementation challenges include resource constraints, fragmented data systems, weak investigations, supplier variability and the need to maintain consistent standards across sites and markets. The review concludes that an integrated quality culture linking QC, QA, manufacturing, regulatory affairs and management is essential for dependable medicines and sustainable compliance.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24412887
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Comprehensive Review Of Quality Control And Quality Assurance In The Pharmaceutical Industry

Jay Thorat, Bhavana Tonde, Snehal Fand, Shital Thorat
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Quality and Counterfeiting
article

A Comprehensive Review Of Quality Control And Quality Assurance In The Pharmaceutical Industry

Jay Thorat, Bhavana Tonde, Snehal Fand, Shital Thorat
article en

Abstract

Absrtact: Quality is a central requirement in pharmaceutical products because medicines must consistently meet predefined standards of identity, strength, purity, safety and performance. Quality Control (QC) provides sampling, testing and analytical evidence about materials and products, while Quality Assurance (QA) builds a documented system that prevents errors and ensures that work is performed according to approved procedures. This review synthesises key principles across the major areas of a pharmaceutical QC–QA curriculum: good practices and pharmaceutical quality systems; testing of raw materials, packaging components, in-process samples and finished dosage forms; regulatory authorities and drug-development submissions; documentation and data integrity; qualification, calibration and validation; cleaning and analytical-method validation; Quality by Design (QbD), Process Analytical Technology (PAT), audits and intellectual-property basics. International guidance from WHO, ICH and the US FDA is considered alongside the Indian regulatory context. The literature and guidance indicate that reliable quality depends on a lifecycle approach rather than end-product testing alone. Risk-based decisions, trained personnel, suitable facilities, validated processes, trustworthy data, change control and continual improvement work together to reduce patient risk. Implementation challenges include resource constraints, fragmented data systems, weak investigations, supplier variability and the need to maintain consistent standards across sites and markets. The review concludes that an integrated quality culture linking QC, QA, manufacturing, regulatory affairs and management is essential for dependable medicines and sustainable compliance.

Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
A Comprehensive Review Of Quality Control And Quality Assurance In The Pharmaceutical Industry — Jay Thorat, Bhavana Tonde, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS